Legislation - Pharmaceutical Executive



Action Amid Uncertainty: Preparing for Health Reform

October 14, 2009

As the health care reform debate continues to rage on Capitol Hill, pharma companies should be engaged in intense strategic planning for the future. Putting together a game plan now for the most likely reform scenarios will help companies to stay ahead of the curve.

Washington Report: A Full Plate

January 1, 2007

The anticipated Congressional free-for-all on the Bush administration will put FDA officials in the hot seat. There will be hearings on inadequate oversight of drug safety, conflicts of interest, importation, and hasty approvals.

Washington Report: The New Agenda

December 1, 2006

The Democrats are back in power in Congress, and they have their eyes on the drug industry. Look for hearings, investigations, an attack on the Medicare 'non-interference' clause, and a tough PDUFA reauthorization.

Global Report: 'Bout Time

November 1, 2006

Pfizer says it is trying to stamp out counterfeiting by consolidating under one drug distributor. Critics think otherwise.


Click here